Literature DB >> 17671454

PIM1 and MYC: a changing relationship?

Jean-Francois Naud, Martin Eilers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17671454     DOI： 10.1038/ncb0807-873

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN： 1465-7392            Impact factor:   28.824


× No keyword cloud information.
  6 in total

Review 1.  c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.

Authors:  Chenguang Wang; Yanhong Tai; Michael P Lisanti; D Joshua Liao
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

Review 2.  For better or for worse: the role of Pim oncogenes in tumorigenesis.

Authors:  Martijn C Nawijn; Andrej Alendar; Anton Berns
Journal:  Nat Rev Cancer       Date:  2010-12-09       Impact factor: 60.716

3.  Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival.

Authors:  Susann Herzog; Matthias Alexander Fink; Kerstin Weitmann; Claudius Friedel; Stefan Hadlich; Sönke Langner; Katharina Kindermann; Tobias Holm; Andreas Böhm; Eskil Eskilsson; Hrvoje Miletic; Markus Hildner; Michael Fritsch; Silke Vogelgesang; Christoph Havemann; Christoph Alexander Ritter; Henriette Elisabeth Meyer zu Schwabedissen; Bernhard Rauch; Wolfgang Hoffmann; Heyo Klaus Kroemer; Henry Schroeder; Sandra Bien-Möller
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

4.  Signaling events involved in interleukin 27 (IL-27)-induced proliferation of human naive CD4+ T cells and B cells.

Authors:  Pascaline Charlot-Rabiega; Emilie Bardel; Céline Dietrich; Robert Kastelein; Odile Devergne
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

Review 5.  Cancer gene discovery in mouse and man.

Authors:  Jenny Mattison; Louise van der Weyden; Tim Hubbard; David J Adams
Journal:  Biochim Biophys Acta       Date:  2009-03-12

6.  Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185.

Authors:  Yoko Tabe; Kensuke Kojima; Shinichi Yamamoto; Kazumasa Sekihara; Hiromichi Matsushita; Richard Eric Davis; Zhiqiang Wang; Wencai Ma; Jo Ishizawa; Saiko Kazuno; Michael Kauffman; Sharon Shacham; Tsutomu Fujimura; Takashi Ueno; Takashi Miida; Michael Andreeff
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.